July 13, 2026

Becton, Dickinson and Company (BDX) Stock Analysis: A 16% Upside Opportunity in the Healthcare Sector

As individual investors explore opportunities in the diverse landscape of healthcare, Becton, Dickinson and Company (NYSE: BDX) presents a compelling case for consideration. With a robust market cap of $41.87..

Stevanato Group S.p.A. (STVN) Stock Analysis: Exploring a 24.81% Potential Upside

Stevanato Group S.p.A. (NYSE: STVN), headquartered in Piombino Dese, Italy, stands as a significant contender in the healthcare sector, specifically within the medical instruments and supplies industry. As of the..

Eli Lilly and Company (LLY) Stock Analysis: Exploring the Potential Within a $1.06 Trillion Market Cap Giant

Eli Lilly and Company (NYSE: LLY), a stalwart in the healthcare sector, is making waves with its impressive market presence and innovative pharmaceutical offerings. With a staggering market capitalization of..

Masimo Corporation (MASI): Analyst Consensus and Growth Potential in the Healthcare Sector

Masimo Corporation (NASDAQ: MASI), a prominent player in the medical devices industry, continues to capture investor attention with its innovative patient monitoring technologies. Headquartered in Irvine, California, Masimo is known..

Takeda Pharmaceutical Company L (TAK) Stock Analysis: Evaluating a 26.70% Potential Upside with Strong Buy Ratings

Takeda Pharmaceutical Company Limited (NYSE: TAK), a titan in the healthcare sector, stands as a prominent player in the drug manufacturing industry with a market capitalization of $52.88 billion. Headquartered..

Amgen Inc. (AMGN) Stock Analysis: Navigating a Sturdy Healthcare Giant with a 2.77% Dividend Yield

Amgen Inc. (NASDAQ: AMGN), a titan in the healthcare sector, continues to stand out amidst the bustling landscape of drug manufacturers. With a market capitalization of $196.12 billion, Amgen’s robust..

Regeneron Pharmaceuticals (REGN): Investor Outlook on Its 23.77% Potential Upside

Regeneron Pharmaceuticals, Inc. (REGN), a heavyweight in the biotechnology sector, is garnering attention from investors due to its considerable market presence and promising growth potential. Currently trading at $664.52, the..

DexCom, Inc. (DXCM) Stock Analysis: Strong Analyst Consensus and Promising Growth Potential

DexCom, Inc. (NASDAQ: DXCM) stands as a key player in the healthcare sector, specifically within the medical devices industry, focusing on the development and commercialization of continuous glucose monitoring (CGM)..

HealthEquity, Inc. (HQY) Stock Analysis: Exploring a Potential 22.42% Upside with Strong Buy Ratings

HealthEquity, Inc. (NASDAQ: HQY) offers a compelling investment opportunity in the healthcare sector, primarily focusing on health information services. With a current market capitalization of $7.89 billion, this U.S.-based company..

Bristol-Myers Squibb (BMY): Investor Outlook on Growth Potential and Dividend Stability

Bristol-Myers Squibb Company (NYSE: BMY) remains a significant player in the healthcare sector, with a focus on the development and distribution of biopharmaceutical products. As a key entity within the..

Thermo Fisher Scientific Inc (TMO) Stock Analysis: A 12% Upside in Healthcare Innovation

Thermo Fisher Scientific Inc (NYSE: TMO), a titan in the healthcare sector, continues to capture investor attention with a robust market cap of $195.86 billion. As a leader in diagnostics..

Koninklijke Philips N.V. (PHG) Stock Analysis: Assessing a 21% Potential Upside in the Healthcare Sector

Investors eyeing opportunities in the healthcare sector may want to consider Koninklijke Philips N.V. (NYSE: PHG), a prominent player in the medical devices industry based in the Netherlands. With a..

Boston Scientific Corporation (BSX) Stock Analysis: A Promising 64.98% Upside Awaits Investors

Boston Scientific Corporation (NYSE: BSX) stands at the forefront of the medical devices industry, boasting a market capitalization of $66.54 billion. The Marlborough, Massachusetts-based company has carved a niche in..

AptarGroup, Inc. (ATR) Stock Analysis: Exploring a 27.80% Upside Potential

For investors seeking opportunities in the healthcare sector, AptarGroup, Inc. (NYSE: ATR) presents a compelling case. With a robust market capitalization of $8.01 billion, this Illinois-based company has carved a..

Baxter International Inc. (BAX) Stock Analysis: Navigating a Challenging Healthcare Landscape with a 0.88% Dividend Yield

For investors eyeing opportunities within the healthcare sector, Baxter International Inc. (NYSE: BAX) presents a complex but potentially rewarding proposition. With a current market capitalization of $11.68 billion, Baxter stands..

Solventum Corporation (SOLV) Stock Analysis: Evaluating a 7% Potential Upside Amidst Sector Challenges

For investors searching for opportunities in the healthcare sector, Solventum Corporation (SOLV) presents a unique proposition. With a market capitalization of $13.28 billion, Solventum operates within the Medical Instruments &..

Alcon Inc. (ALC) Stock Analysis: A 29.66% Potential Upside in the Eye Care Sector

Alcon Inc. (NYSE: ALC), a leader in the global eye care sector, is capturing investor attention with its robust growth metrics and a substantial potential upside of 29.66%, as indicated..

Intuitive Surgical, Inc. (ISRG) Stock Analysis: A 38% Upside Potential Combined with Strong Revenue Growth

Intuitive Surgical, Inc. (NASDAQ: ISRG) stands at the forefront of the healthcare sector, renowned for its innovative contributions to medical instruments and supplies. With a market capitalization of $144.07 billion,..

Zimmer Biomet Holdings, Inc. (ZBH) Stock Analysis: Is the 7.34% Potential Upside Worth Your Investment?

Zimmer Biomet Holdings, Inc. (NYSE: ZBH), a prominent player in the healthcare sector, operates at the intersection of medical technology and orthopedics. With a commanding market capitalization of $17.67 billion,..

Neurocrine Biosciences, Inc. (NBIX) Stock Analysis: Unveiling a 11.77% Potential Upside in the Healthcare Sector

Neurocrine Biosciences, Inc. (NBIX) stands out as a compelling player in the healthcare sector, particularly within the niche of drug manufacturers specializing in neurological, psychiatric, endocrine, and immunological disorders. With..

Search

Funds

July 13, 2026

Search

Funds

July 13, 2026

FTSE 100

Funds